1338922-79-4

Basic information

• Product Name: (R)-2-(1-(3,4-dichlorophenyl)-1-phenylbutyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
• Synonyms: (R)-2-(1-(3,4-dichlorophenyl)-1-phenylbutyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
• CAS NO: 1338922-79-4
• Molecular Weight: 405.172
• Mol File: 1338922-79-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (R)-2-(1-(3,4-dichlorophenyl)-1-phenylbutyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-2-(1-(3,4-dichlorophenyl)-1-phenylbutyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane(1338922-79-4)
• EPA Substance Registry System: (R)-2-(1-(3,4-dichlorophenyl)-1-phenylbutyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane(1338922-79-4)

Safety Data

• Hazardous Substances Data: 1338922-79-4(Hazardous Substances Data)

Upstream product

• 151169-75-4 3,4-dichlophenylboronic acid 
• 76-09-5 2,3-dimethyl-2,3-butane diol 
• 1338922-78-3 C₁₇H₂₇NO₂ 
• 401797-02-2 2-(3,4-dichlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 

Downstream Products

• 1338922-84-1 (R)-1,2-dichloro-4-(1-phenylbutyl)benzene 

Relevant articles and documents

Enantioselective syntheses of (+)-sertraline and (+)-indatraline using lithiation/borylation-protodeboronation methodology

The lithiation/borylation-protodeboronation of a homoallyl carbamate was applied to the synthesis of (+)-sertraline and (+)-indatraline. Due to the presence of the alkene, significant modifications of the methodology were required (use of 12-crown-4, TMSCl, H2O), or a solvent switch to CHCl3, to achieve high yields and high selectivities.